COMPARATIVE EFFICACY OF ESMOLOL AND DEXMEDETOMIDINE IN ACHIEVING CONTROLLED HYPOTENSION DURING FUNCTIONAL ENDOSCOPIC SINUS SURGERY: A RANDOMIZED DOUBLE-BLIND STUDY
DOI:
https://doi.org/10.22159/ijcpr.2025v17i2.6078Keywords:
Functional endoscopic sinus surgery, Esmolol, Dexmedetomidine, Hemodynamic stability, Intraoperative blood lossAbstract
Objective: Functional Endoscopic Sinus Surgery (FESS) is a prevalent procedure in otorhinolaryngology, often complicated by excessive intraoperative bleeding, which impairs surgical visibility. Controlled hypotensive anesthesia is employed to mitigate blood loss and enhance the surgical field. Esmolol, an ultra-short-acting beta-blocker, and Dexmedetomidine, a selective α₂-adrenergic agonist, are two agents commonly used to achieve controlled hypotension. This study aims to compare the efficacy and safety of esmolol versus dexmedetomidine in maintaining controlled hypotension during FESS.
Methods: A prospective, double-blind, randomized interventional study was conducted involving 60 patients aged 18-65 years with ASA Grade I-II, scheduled for FESS under general anesthesia. Participants were randomly allocated into two groups: Group A received an esmolol bolus of 1 mg/kg over 1 minute followed by an infusion of 1 mg/kg/h, while Group B received a dexmedetomidine bolus of 1 µg/kg over 10 min followed by an infusion of 0.5 µg/kg/hr. Hemodynamic parameters, blood loss, duration of surgery, quality of the surgical field, recovery time, analgesic requirements, and complications were recorded and analyzed.
Results: Both esmolol and dexmedetomidine groups achieved significant reductions in mean arterial pressure (MAP) without significant differences between the groups. Blood loss and duration of surgery were comparable. Dexmedetomidine was associated with a significantly longer time to first rescue analgesic (58.7±5.09 min vs. 29.83±4.38 min, p<0.001) and prolonged emergence time (7.45±0.98 min vs. 4.45±0.97 min, p<0.001) compared to esmolol. Heart rate was significantly lower in the dexmedetomidine group throughout the surgery (p<0.001). Complication rates were similar between groups.
Conclusion: Both esmolol and dexmedetomidine are effective and safe for achieving controlled hypotension in FESS, providing hemodynamic stability and minimal blood loss. Dexmedetomidine offers superior postoperative analgesia but is associated with delayed emergence, whereas esmolol allows for quicker recovery. Choice of agent can be tailored based on patient-specific requirements and surgical considerations.
Downloads
References
Illum P, Jeppesen F. Sinoscopy: endoscopy of the maxillary sinus. Technique common and rare findings. Acta Oto Laryngol. 1972 Jun;73(6):506-12. doi: 10.3109/00016487209138972, PMID 5047113.
Kennedy DW. Technical innovations and the evolution of endoscopic sinus surgery. Ann Otol Rhinol Laryngol Suppl. 2006 Sep;196:3-12. doi: 10.1177/00034894061150s902, PMID 17040012.
Wormald PJ, Hoseman W, Callejas C, Weber RK, Kennedy DW, Citardi MJ. The international frontal sinus anatomy classification (IFAC) and classification of the extent of endoscopic frontal sinus surgery (EFSS). Int Forum Allergy Rhinol. 2016 Jul;6(7):677-96. doi: 10.1002/alr.21738, PMID 26991922.
Hosemann W, Draf C. Danger points complications and medico legal aspects in endoscopic sinus surgery. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2013 Dec 13;12:6. doi: 10.3205/cto000098, PMID 24403974.
Weber RK. Comprehensive review on endonasal endoscopic sinus surgery. Laryngorhinootologie. 2015 Mar;94 Suppl 1:S64-S142. doi: 10.1055/s-0035-1545353, PMID 25860497.
Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma. 2002 Jun;52(6):1141-6. doi: 10.1097/00005373-200206000-00020, PMID 12045644.
Praveen K, Narayanan V, Muthusekhar MR, Baig MF. Hypotensive anaesthesia and blood loss in orthognathic surgery: a clinical study. Br J Oral Maxillofac Surg. 2001 Apr;39(2):138-40. doi: 10.1054/bjom.2000.0593, PMID 11286449.
Kim DH, Lee J, Kim SW, Hwang SH. The efficacy of hypotensive agents on intraoperative bleeding and recovery following general anesthesia for nasal surgery: a network meta-analysis. Clin Exp Otorhinolaryngol. 2021 May;14(2):200-9. doi: 10.21053/ceo.2020.00584, PMID 32847341, PMCID PMC8111392.
Choudhary P, Dutta A, Sethi N, Sood J, Rai D, Gupta M. Pre-induction fentanyl dose-finding study for controlled hypotension during functional endoscopic sinus surgery. Indian J Anaesth. 2019;63(8):653-9. doi: 10.4103/ija.IJA_866_18, PMID 31462812.
Rodrigo C. Induced hypotension during anesthesia with special reference to orthognathic surgery. Anesth Prog. 1995;42(2):41-58. PMID 8934953.
Gardner WJ. The control of bleeding during operation by induced hypotension. JAMA. 1946;132(10):572-4. doi: 10.1001/jama.1946.02870450026007, PMID 21001599.
Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119(3):507-15. doi: 10.1097/ALN.0b013e3182a10e26, PMID 23835589.
Degoute CS. Controlled hypotension: a guide to drug choice. Drugs. 2007;67(7):1053-76. doi: 10.2165/00003495-200767070-00007, PMID 17488147.
Hodge K, Ward PA, Irwin MG. Hypotensive anaesthesia. In: Ward PA, Irwin MG, editors. Oxford textbook of anaesthesia for oral and maxillofacial surgery. 2nd ed. Oxford: Oxford Academic; 2022. p. 77-C7.P62. doi: 10.1093/med/9780198790723.003.0007.
Cardesin A, Pontes C, Rosell R, Escamilla Y, Marco J, Escobar MJ. Hypotensive anaesthesia and bleeding during endoscopic sinus surgery: an observational study. Eur Arch Otorhinolaryngol. 2014;271(6):1505-11. doi: 10.1007/s00405-013-2700-0, PMID 24052249.
Barbier GH, Shettigar UR, Appunn DO. Clinical rationale for the use of an ultra-short-acting beta-blocker: esmolol. Int J Clin Pharmacol Ther. 1995 Apr;33(4):212-8. PMID 7620691.
Mio Y. New ultra short acting beta-blockers: landiolol and esmolol the effects on cardiovascular system. Masui. 2006 Jul;55(7):841-8. PMID 16856544.
Angaran DM, Schultz NJ, Tschida VH. Esmolol hydrochloride: an ultrashort acting beta-adrenergic blocking agent. Clin Pharm. 1986 Apr;5(4):288-303. doi: 10.1093/ajhp/43.5.1322, PMID 2871961.
Gupta K, Bansal M, Gupta PK, Pandey M, Agarwal S. Dexmedetomidine infusion during middle ear surgery under general anaesthesia to provide oligaemic surgical field: a prospective study. Indian J Anaesth. 2015;59(1):26-30. doi: 10.4103/0019-5049.149445, PMID 25684810.
Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology. 1992 Dec;77(6):1134-42. doi: 10.1097/00000542-199212000-00014, PMID 1361311.
Tegegne SS, Gebregzi AH, Arefayne NR. Deliberate hypotension as a mechanism to decrease intraoperative surgical site blood loss in resource limited setting: a systematic review and guideline. International Journal of Surgery Open. 2021;29(7):55-65. doi: 10.1016/j.ijso.2020.11.019.
Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative analgesic agent. Proc (Bayl Univ Med Cent). 2001;14(1):13-21. doi: 10.1080/08998280.2001.11927725, PMID 16369581.
Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications. Curr Opin Anaesthesiol. 2008;21(4):457-61. doi: 10.1097/ACO.0b013e328305e3ef, PMID 18660652.
Shams T, El Bahnasawe NS, Abu Samra M, El Masry R. Induced hypotension for functional endoscopic sinus surgery: a comparative study of dexmedetomidine versus esmolol. Saudi J Anaesth. 2013 Apr;7(2):175-80. doi: 10.4103/1658-354X.114073, PMID 23956719, PMCID PMC3737695.
Bajwa SJ, Kaur J, Kulshrestha A, Haldar R, Sethi R, Singh A. Nitroglycerine esmolol and dexmedetomidine for induced hypotension during functional endoscopic sinus surgery: a comparative evaluation. J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):192-7. doi: 10.4103/0970-9185.173325, PMID 27275048, PMCID PMC4874073.
Damarla P, Mamidi P. Dexmedetomidine and esmolol for induced hypotension for functional endoscopic sinus surgery. Nat J Physiol Pharmacol Pharm Res. 2022;12:3.
Degoute CS, Ray MJ, Manchon M, Dubreuil C, Banssillon V. Remifentanil and controlled hypotension; comparison with nitroprusside or esmolol during tympanoplasty. Can J Anaesth. 2001;48(1):20-7. doi: 10.1007/BF03019809, PMID 11212044.
Richa F, Yazigi A. Effect of dexmedetomidine on blood pressure and bleeding in maxilla facial surgery. Eur J Anaesthesiol. 2007;24(11):985-6. doi: 10.1017/s0265021507001081, PMID 18035604.
Durmus M, But AK, Dogan Z, Yucel A, Miman MC, Ersoy MO. Effect of dexmedetomidine on bleeding during tympanoplasty or septorhinoplasty. Eur J Anaesthesiol. 2007;24(5):447-53. doi: 10.1017/S0265021506002122, PMID 17241505.
Sidhwani Valecha D, Gandhi M, KK A. Comparison of dexmedetomidine and esmolol for induction of controlled hypotension in spine surgeries. J Evol Med Dent Sci. 2016;5(35):2030-5. doi: 10.14260/jemds/2016/477.
Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative analgesic agent. Proc (Bayl Univ Med Cent). 2001 Jan;14(1):13-21. doi: 10.1080/08998280.2001.11927725, PMID 16369581, PMCID PMC1291306.
Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative analgesic agent. Journal of Baylor Scott & White Health. 2001 Jan;14(1):13-21. doi: 10.1080/08998280.2001.11927725.
Gurbet A, Basagan Mogol E, Turker G, Ugun F, Kaya FN, Ozcan B. Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth. 2006 Jul;53(7):646-52. doi: 10.1007/BF03021622, PMID 16803911.
Ajay K, Ankur G, Malti A. Comparison between intravenous dexmedetomidine and esmolol for induced hypotension during functional endoscopic sinus surgery and modified radical mastoidectomy. MIJOANS. 2018;8(1):29-33. doi: 10.26611/1015816.
Published
How to Cite
Issue
Section
Copyright (c) 2025 CHANDRA KANT SHARMA, MAINA SINGH, RATAN LAL YADAV
This work is licensed under a Creative Commons Attribution 4.0 International License.